Select Biotechnology Portfolio is a registered fund series of Fidelity Select Portfolios (series S000007486). Net assets $5.3B as of 2026-05-31.
Showing 15 of 200 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| KRYSTAL BIOTECH INC | — | $557.1M | 1057.85% |
| ABBVIE INC | — | $485.6M | 922.05% |
| AMGEN INC | — | $343.9M | 652.97% |
| GILEAD SCIENCES INC | — | $253.6M | 481.53% |
| Fidelity Revere Street Trust | — | $176.5M | 335.15% |
| ALNYLAM PHARMACEUTICALS INC | — | $154.5M | 293.42% |
| PRAXIS PRECISION MEDICINES INC. | — | $130.0M | 246.84% |
| INSMED INC | — | $118.6M | 225.19% |
| ARGENX SE | — | $118.2M | 224.54% |
| ASCENDIS PHARMA A/S | — | $107.7M | 204.45% |
| REVOLUTION MEDICINES INC | — | $106.3M | 201.88% |
| UCB SA | — | $105.1M | 199.52% |
| JAZZ PHARMACEUTICALS PLC | — | $97.1M | 184.33% |
| SCHOLAR ROCK HOLDING CORP | — | $81.4M | 154.51% |
| NATERA INC | — | $74.1M | 140.63% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $5.3B |
| 2026-02-28 | $5.4B |
| 2025-11-30 | $5.3B |
| 2025-08-31 | $4.2B |
| 2025-05-31 | $3.7B |
| 2025-02-28 | $4.3B |
| 2024-11-30 | $4.8B |
| 2024-08-31 | $5.0B |